Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001395504/en/
Thermo Fisher Bioanalytical lab
The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and strengthen the life science ecosystem. A dedicated team from Thermo Fisher will co-locate with AstraZeneca scientists to work on collaborative R&D projects with a focus initially on chromatography, molecular genomics and proteomics.
"This is a unique opportunity to co-locate with AstraZeneca scientists, driving collaborative innovation, strengthening the science ecosystem and driving value generation for all collaborators, giving easy access to cutting edge technologies for emerging life sciences and biotech companies as well as academic groups,” said Leon Wyszkowski, president, analytical services, clinical research, Thermo Fisher Scientific. “This partnership will enable advancements in areas such as drug and analytical development, further bringing to life Thermo Fisher's mission to enable our customers to make the world healthier, cleaner and safer."
“When two global life science leaders join forces in an open innovation environment, truly exceptional conditions for breakthrough discovery and progress are created. Welcoming Thermo Fisher Scientific into BioVentureHub at AstraZeneca’s strategic R&D campus in Gothenburg - adjacent to GoCo Health Innovation City - marks a significant step and unlocks dynamic opportunities for open scientific co-creation between AstraZeneca and Thermo Fisher Scientific. We are pleased to welcome the Thermo Fisher team and look forward to a highly productive partnership,"Magnus Björsne, CEO, AstraZeneca BioVentureHub said.
The AstraZeneca BioVentureHub is part of a growing innovation ecosystem in Gothenburg that includes the GoCo Health Innovation City, future home of Thermo Fisher's bioanalytical laboratory that is under construction and expected to begin operations in March 2026. This state-of-the-art facility will serve pharmaceutical and biotech customers in Europe and across the globe, providing leading-edge bioanalytical laboratory capabilities to support all phases of pharmaceutical development to help customers deliver life-changing medicines to patients worldwide.
In addition to the new lab coming online in Sweden, the business operates a global network of GMP (good manufacturing practices), central, bioanalytical and vaccine science laboratories with operations based in Middleton, Wisconsin; Highland Heights, Kentucky; Richmond, Virginia; Athlone, Ireland; Brussels, Belgium; Singapore; and Suzhou, China.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com.
About AstraZeneca BioVentureHub
AstraZeneca BioVentureHub is a unique open innovation platform, offering an inside track to AstraZeneca's scientific expertise, world-class infrastructure, and facilities. Integrated at the heart of AstraZeneca's strategic R&D site in Gothenburg, the BioVentureHub enables emerging life science companies and academia to work and grow within our focus areas: Pharma, DeepTech, Digital & SustainTech.
We promote innovation by connecting, catalyzing, and nurturing the right parties to form valuable collaborations that drive growth for all involved. Our unique dare-to-share culture, trust, and scientific curiosity, together with non-competitive synergies, are at the core of being part of the BioVentureHub. All BioVentureHub companies operate independently, and AstraZeneca holds no ownership or innovation rights. The BioVentureHub is a fusion of minds and resources leading to groundbreaking innovations and industry leadership. We believe in Growing Innovation Together. For more information, please visit www.azbioventurehub.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251001395504/en/
Contacts
Media Contact Information:
Mike Lawrence
Director Communications,
Thermo Fisher Scientific
ppdmedia@thermofisher.com
Magnus Björsne
CEO of AstraZeneca BioVentureHub,
Head of BioVenture Innovation Unit.
magnus.bjorsne@astrazeneca.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SPIE Photonics West 2026 Opens for Registration1.10.2025 21:48:00 EEST | Press release
Registration has opened for SPIE Photonics West 2026, which will run from 17 to 22 January at San Francisco’s Moscone Center. The largest annual conference and exhibition in optics and photonics, Photonics West brings together researchers, innovators, engineers, and business leaders from across the globe for an exciting week of research sharing, thought leadership, and innovation-inspiring exchanges. With more than100 technical conferences and 150 special events complementing the 1,200-plus companies at the exhibitions, the dynamic week will once again provide all attendees with an exhilarating experience that showcases the best of photonics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001765437/en/ A bustling Moscone Center in San Francisco during 2025's SPIE Photonics West. SPIE Photonics West will have six major application areas presenting the latest technologies and discoveries that utilize optics and photonics. B
Stefanini Group Acquires Cyber Smart Defense to Bolster Global Cybersecurity Portfolio, Better Serve Clients1.10.2025 20:35:00 EEST | Press release
Stefanini Group, a $1 billion global technology company specializing in digital solutions, announced today the initiation of its merger with Cyber Smart Defense, a Romanian cybersecurity company, which will enable Stefanini to strengthen its cybersecurity capabilities in Europe. Effective today, Stefanini Group will acquire 100% of Cyber Smart Defense’s Romanian operations, solidifying a partnership that began in 2020. "The Cyber Smart Defense acquisition is a game-changer for our clients in Romania, and this merger marks a strategic step forward in our plan to increase our cybersecurity offerings in the European market," said Farlei Kothe, CEO of Stefanini Group's North America, APAC, and EMEA regions. "The addition of this company’s talented professionals will further expand our capabilities, enabling Stefanini to offer a broader and more efficient range of solutions to our clients.” Having acquired more than 40 companies, Stefanini Group announced in April a new global portfolio org
QNB Group Receives Saudi Central Bank “SAMA” License Approval for a New Digital Bank “ezbank”1.10.2025 19:20:00 EEST | Press release
QNB Group, the largest financial institution in the Middle East and Africa, announced the license approval has been received for a digital-first banking entity, ezbank, from the Saudi Central Bank ”SAMA”, in cooperation with Ajlan & Bros. Holding, with a capital of SAR 2.5 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001012393/en/ QNB Group Corporate Headquarters (Photo: AETOSWire) This milestone, in cooperation with Ajlan & Bros. Holding, reflects a commitment to supporting QNB Group’s vision for financial inclusion and digital transformation, as well as the broader economic development strategy. With ezbank, the goal is to introduce a new model of customer-centric banking built around innovation, efficiency, and accessibility. The license approval for ezbank is an important step in QNB Group’s ongoing efforts to transform the banking sector in the markets in which it operates, across over 28 countries in 3 co
CompareForexBrokers: Seven Major Forex Pairs Slip to 66.3% of Global Turnover1.10.2025 18:02:00 EEST | Press release
CompareForexBrokers has analysed the latest Triennial Survey from the Bank for International Settlements, published 30 September 2025, and found the seven major currency pairs are losing dominance in global foreign exchange markets. While 85% of forex transactions consisted of the seven majors in 2022, their share has since dropped to 66.3% in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001844788/en/ Daily Turnover On Forex Markets Despite the 18.7% drop in major pairs, overall activity has increased considerably, with daily turnover rising 28% to 9.6 trillion USD. On an annual basis, that equates to 3.5 quadrillion USD, up from 2.73 quadrillion in 2022. More data can be found on the forex statistics page. “Our biggest take away from yesterday’s BIS data release is foreign exchange remains the largest financial market, but the composition of trading is changing,” said Justin Grossbard, co-founder of CompareForexB
Pure Lithium Partners with Voltaiq to Accelerate Commercialization1.10.2025 16:15:00 EEST | Press release
Pure Lithium, a disruptive vertically integrated lithium metal battery technology company, has selected Voltaiq’s Enterprise Battery Intelligence platform to provide battery analytics and quality control that are essential to Pure Lithium’s drive to commercialize its next generation lithium metal battery, the two companies announced today. The partnership with Voltaiq, the industry leader in battery quality analytics software, comes at a crucial time for Pure Lithium as it relocates to Chicago, builds out its first pilot line, and begins shipping sample cells to customers. Pure Lithium previously relied on its own internal analytics system. As the company shifts focus from R&D to commercialization, the team turned to Voltaiq to provide a platform that can scale with the business – including advanced analytics – as well as a partner with deep battery and software expertise. In manufacturing applications, Voltaiq can catch battery defects weeks sooner than other QC methods, accelerating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom